Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2023-01-10

Clinical Trial Update: Efficacy, Tolerability, and Safety of DFN-15 [Phase 3]

View source ↗

Summary

Phase 3 trial updates report on efficacy, tolerability, and safety of DFN-15 for migraine, with completed status and posted results.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • DFN-15 (DFN-15)

Snippet

Sponsor: BioDelivery Sciences International | Conditions: Migraine Headache | Phase 3 | Status: COMPLETED | Results posted: 2023-01-10